THE POTENTIAL DANGER TO ASCVD RISK REDUCTION: A RARE CASE OF INCLISIRAN INDUCED VASCULITIS
Therapeutic Area: Pharmacologic Therapy Case Presentation: A 62-year-old male with coronary artery disease, hypertension, hyperlipidemia, and osteoarthritis complained of arthralgias, pharyngeal ulcers, ear fullness, and subjective fever. Symptoms began after receiving his inclisiran injection. Phys...
Saved in:
Main Author: | Sumair Ozair, DO (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retrospective Evaluation of LDL-C Levels Following First Treatment With Inclisiran as Part of Secondary Prevention ASCVD Risk Reduction in a Real-World Primary Care Setting
by: Carl N. Deaney, et al.
Published: (2024) -
Inclisiran for the treatment of hypercholesterolaemia
by: Joel C Marrs, et al.
Published: (2024) -
Inclisiran - hope in the fight against dyslipidemia
by: Paulina Krawiec, et al.
Published: (2023) -
COVID-19 associated risks of myocardial infarction in persons with familial hypercholesterolemia with or without ASCVD
by: Kelly D. Myers, et al.
Published: (2021) -
Vancomycin-Induced Leukocytoclastic Vasculitis: A Rare Case Report
by: Pratibha Sharma MBBS, et al.
Published: (2018)